Your browser doesn't support javascript.
loading
Dynamics of Epstein-Barr virus on post-transplant lymphoproliferative disorders after antithymocyte globulin-conditioned allogeneic hematopoietic cell transplant.
Lindsay, Julian; Othman, Jad; Yong, Michelle K; Ritchie, David; Chee, Lynette; Tay, KimHeng; Tio, Shio Yen; Kerridge, Ian; Fay, Keith; Stevenson, William; Arthur, Chris; Chen, Sharon C-A; Kong, David C M; Greenwood, Matthew; Pergam, Steven A; Liu, Catherine; Slavin, Monica A.
  • Lindsay J; National Centre for Infection in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Othman J; Haematology Department, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Yong MK; Vaccine and Infectious Disease and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Ritchie D; Haematology Department, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Chee L; National Centre for Infection in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Tay K; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Tio SY; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Kerridge I; Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Fay K; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.
  • Stevenson W; Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Arthur C; Department of Medicine, University of Melbourne, Parkville, Victoria, Australia.
  • Chen SC; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Kong DCM; National Centre for Infection in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Greenwood M; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Pergam SA; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Liu C; Haematology Department, Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Slavin MA; Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Transpl Infect Dis ; 23(5): e13719, 2021 Oct.
Article en En | MEDLINE | ID: mdl-34453768
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Infecciones por Virus de Epstein-Barr / Trastornos Linfoproliferativos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Infecciones por Virus de Epstein-Barr / Trastornos Linfoproliferativos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article